These results showed that GYY4137 improved myocardial fibrosis, possibly through a mechanism involving inhibition of oxidative stress, blockade of the TGF-β1/smad2 signaling pathway and decreased expression of α-SMA in cardiac fibroblasts [150]. The gene discussed is ACTA1; the disease is Myocardial fibrosis.